| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/15/2001 | WO2000061609A3 Prodrugs of thrombin inhibitors |
| 03/15/2001 | WO2000053730A3 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 03/15/2001 | WO2000053583A8 Inhibitors of protein tyrosine phosphatase |
| 03/15/2001 | WO2000044398A3 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions |
| 03/15/2001 | WO2000024419A8 Methods for enhancing wound healing |
| 03/15/2001 | WO2000002578A8 Remedies for apoptosis-associated diseases |
| 03/15/2001 | WO1999062545A3 GnRH VACCINES FOR SUPPRESSING REPRODUCTIVE BEHAVIOUR IN ANIMALS |
| 03/15/2001 | WO1999053076A9 Tao protein kinases and methods of use therefor |
| 03/15/2001 | US20010000036 Micronized dyes, drugs, carotenoids, etc. formed by dissolving in a fluid gas, e.g. carbon dioxide, nitrogen, and the loaded fluid gas dissolved in water or a solvent; then decompression; protective bubbles; antiagglomerants |
| 03/15/2001 | DE19943839A1 Contactinhibin enthaltendes Arzneimittel sowie Arzneimittel, das gegen Contactinhibin gerichtete Antikörper enthält Contactinhibin medicated and drug containing antibodies directed against contactinhibin |
| 03/15/2001 | DE19943787A1 Antiviral agent, e.g. vaccine, antibody, agent that inhibits viral replication, transcription or translation, useful for preventing or treating tumors (or conditions which may become tumorous) associated with viral infections |
| 03/15/2001 | DE19943460A1 New fermentatively produced lipopeptide mixture useful for control of bacterial and fungal infections in medicine and plant protection and as antitumor agent |
| 03/15/2001 | DE19943392A1 Katalase enthaltendes Hautbehandlungsmittel Catalase-containing skin treatment composition |
| 03/15/2001 | DE19942230A1 Verfahren zur Anwendung natriuretischer Peptide als antibiotisch wirksame Substanzen zur Behandlung von bakteriellen Infektionen Method of using natriuretic peptides as antibiotic substances for the treatment of bacterial infections |
| 03/15/2001 | DE19941897A1 New deletion mutants of Interleukin-6 receptor protein useful for production of cell proliferation inhibitors for treatment of tumors, especially multiple myeloma |
| 03/15/2001 | DE19937304A1 Verwendung von CGRP-Antagonisten und CGRP-Release-Hemmern zur Bekämpfung menopausaler Hitzewallungen Use of CGRP antagonists and CGRP release inhibitors to combat menopausal hot flashes |
| 03/15/2001 | DE19925668A1 Spleißosomprotein und seine Verwendung Spleißosomprotein and its use |
| 03/15/2001 | CA2403330A1 Method for producing active serine proteases and inactive variants |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2388562A1 Mammalian cytokines; related reagents and methods |
| 03/15/2001 | CA2386555A1 Gamma-carboxyglutamate containing conopeptides |
| 03/15/2001 | CA2384672A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384663A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | CA2384658A1 Neurogenic compositions and methods |
| 03/15/2001 | CA2384650A1 Apoptosis proteins |
| 03/15/2001 | CA2384634A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | CA2384499A1 Ovarian tumor sequences and methods of use therefor |
| 03/15/2001 | CA2384456A1 Antisense modulation of x-linked inhibitor of apoptosis expression |
| 03/15/2001 | CA2384115A1 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
| 03/15/2001 | CA2384104A1 Use of semaphorin for modulation of cellular efflux |
| 03/15/2001 | CA2384101A1 Tyrosine kinase inhibitors |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2384083A1 Human neuropeptide receptor |
| 03/15/2001 | CA2384076A1 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | CA2384006A1 A minimal tau peptide for the nucleation of paired helical filaments |
| 03/15/2001 | CA2383981A1 Integrin-mediated drug targeting |
| 03/15/2001 | CA2383800A1 52 human secreted proteins |
| 03/15/2001 | CA2383798A1 Pulmonary delivery for bioconjugation |
| 03/15/2001 | CA2383794A1 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | CA2383788A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2383758A1 Novel compound f-15078 |
| 03/15/2001 | CA2383720A1 Composition comprising an alpha-amylase inhibitor and at least one physiologically acceptable compound capable of reducing intestinal absorption of "fast sugars" |
| 03/15/2001 | CA2383638A1 Monomeric analogues of human insulin |
| 03/15/2001 | CA2383419A1 Determination of am-binding proteins and the association of adrenomedullin (am) therewith |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2379532A1 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 03/15/2001 | CA2349434A1 Agents and compositions and methods utilizing same useful in diagnosing and/or treating or preventing plaque forming diseases |
| 03/15/2001 | CA2349207A1 Opg fusion protein compositions and methods |
| 03/15/2001 | CA2348067A1 Composition for extending post meal satiety |
| 03/14/2001 | EP1083227A1 Antibiotic inducible/repressible genetic construct for gene therapy or gene immunization |
| 03/14/2001 | EP1083224A2 Apoptin-associating protein |
| 03/14/2001 | EP1083180A1 Method for searching physiologically active substances, process for producing theses substances and drugs found by the searching method |
| 03/14/2001 | EP1082959A1 NK1 Antagonists for the treatment of depression |
| 03/14/2001 | EP1082908A1 Additives for crustacean or fish feeds and feeds |
| 03/14/2001 | EP1082875A1 Improved brush block housing for propeller deicing system |
| 03/14/2001 | EP1082456A1 Antisense modulation of cd40 expression |
| 03/14/2001 | EP1082445A2 Adeno-associated viral vector-mediated expression of factor viii activity |
| 03/14/2001 | EP1082436A2 Moraxella catarrhalis pilq proteins |
| 03/14/2001 | EP1082433A1 Interleukins-21 and 22 |
| 03/14/2001 | EP1082432A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 03/14/2001 | EP1082431A2 Protease inhibitor peptides |
| 03/14/2001 | EP1082426A2 Human socs proteins |
| 03/14/2001 | EP1082424A1 Tumor suppressor |
| 03/14/2001 | EP1082422A2 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation |
| 03/14/2001 | EP1082421A2 Human bmp-2 promoter and method for exploring bone-related substance by using the same |
| 03/14/2001 | EP1082420A2 Human nucleic acid sequences from normal pancreas tissue |
| 03/14/2001 | EP1082416A2 Poly(adp-ribose)polymerase gene |
| 03/14/2001 | EP1082415A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src |
| 03/14/2001 | EP1082414A1 Carbamoyl phosphate synthase homolog |
| 03/14/2001 | EP1082412A2 Transfected cells and methods for treating diabetes |
| 03/14/2001 | EP1082410A1 Human cd45+ and/or fibroblast + mesenchymal stem cells |
| 03/14/2001 | EP1082346A1 Specific binding proteins for treating canine allergy |
| 03/14/2001 | EP1082345A1 Method of designing agonists and antagonists to egf receptor family |
| 03/14/2001 | EP1082344A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 03/14/2001 | EP1082341A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| 03/14/2001 | EP1082340A1 Peptide vaccine for canine allergy |
| 03/14/2001 | EP1082336A2 Apoptosis modulators that interact with the huntington's disease gene |
| 03/14/2001 | EP1082314A1 New dipeptidyl peptidase iv effectors |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/14/2001 | EP1082142A2 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
| 03/14/2001 | EP1082141A1 Cd40 binding molecules and ctl peptides for treating tumors |
| 03/14/2001 | EP1082139A2 CARRIER FOR $i(IN VIVO) DELIVERY OF A THERAPEUTIC AGENT |
| 03/14/2001 | EP1082137A1 REVERSAL OF PROINFLAMMATORY RESPONSE BY LIGATING THE MACROPHAGE Fc$g(g)RI RECEPTOR |
| 03/14/2001 | EP1082136A1 The cytokine family member, 2-19 |
| 03/14/2001 | EP1082133A2 Pharmaceutical formulations for igf/igfbp |
| 03/14/2001 | EP1082132A1 Recombinant human interferon beta-1a (ifn-beta-1a) formulation |
| 03/14/2001 | EP1082131A2 Immunoregulator |
| 03/14/2001 | EP1082130A1 Use of cyclosporins in the treatment of inflammatory autoimmune diseases |
| 03/14/2001 | EP1082129A1 Method for the treatment of fertility disorders |
| 03/14/2001 | EP1082128A1 Lysine containing peptides for treatment of heart disease |
| 03/14/2001 | EP1082127A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
| 03/14/2001 | EP1082126A1 Novel peptides |
| 03/14/2001 | EP1082105A1 Controlled drug delivery system using the conjugation of drug to biodegradable polyester |
| 03/14/2001 | EP1082104A1 Novel poly(methylidene malonate) microspheres, preparation method and pharmaceutical compositions containing them |
| 03/14/2001 | EP1082103A1 Spill resistant pharmaceutical compositions |
| 03/14/2001 | EP1082096A1 Skin treatment compositions and the use thereof |
| 03/14/2001 | EP1082011A2 Avian polyomavirus vaccines in psittacine birds |
| 03/14/2001 | EP1011767A4 Device for administering insulin in controlled dosages by controlling total inhaled volume |